April 17, 2013 04:08 ET

Market Research Report -- Regulatory Changes Are Major Business Concern for Alternative Power Companies in North America

ROCKVILLE, MD--(Marketwired - Apr 17, 2013) - has announced the addition of the market research report "Global Pharmaceutical Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry" to their product offering.

Executives from the global power industry expect to see increased levels of consolidation, with 50% of respondents anticipating either a significant increase or an increase in M&A activity in 2013. A competitive market, expansion of portfolios, entry in new markets, and weak market conditions are the key stimuli for increasing mergers and acquisitions. Furthermore, respondents across the global power industry anticipate a considerable increase in capital expenditure on 'employee training,' 'sustainable or green initiatives,' and 'new product development.' In addition, respondents across the global power industry anticipate an increase of their current workforce in 2013.

Overall, both groups of respondents identified India, Brazil, the Middle East, and China as the most important regions for growth among emerging markets. The growing economy, increase in industrial output, improvement in lifestyle levels, and use of technologically superior products in households are driving the growth of the power industry in these emerging markets. Additionally, the US, Singapore, Taiwan, Hong Kong, and Australia were identified as the most important growth regions among developed countries; in contrast, France, Spain, and Italy are expected to offer the least growth potential.

'Market uncertainty,' 'cost containment,' and 'regulatory changes' are the immediate business concerns for the global power industry. Although regardless of company size, global power industry companies consider 'market uncertainty' to be the leading business concern, 'regulatory changes' was identified as a more important business concern for respondents from alternative power generator companies and companies in North America. As a result of these concerns, the most important objectives for suppliers were identified as 'engage in partnerships to optimize working capital and reduce costs,' 'innovate products,' and 'improve customer service,' as identified by both buyer and supplier companies. The average size of the annual marketing budget of global pharmaceutical industry supplier respondents stood at US$4.2 million in 2012, a figure that decreased to US$2.6 million in 2013.

For more information, visit

Follow us on Facebook
Follow us on Twitter

About ICD Research

ICD Research is a full-service global market research agency and premium business information brand specializing in industry analysis in a wide set of B2B and B2C markets. ICD Research has access to over 400 in-house analysts and journalists and a global media presence in over 30 professional markets enabling us to conduct unique and insightful research via our trusted business communities. Through its unique B2B and B2C research panels and access to key industry bodies, ICD Research delivers insightful and actionable analysis. The ICD Research survey capabilities grant readers access to the opinions and strategies of key business decision makers, industry experts and competitors as well as examining their actions surrounding business priorities.

About is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. Moreover,'s Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance. For more information, call Cindy Frei at 240.747.3014 or visit